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ABSTRACT
The non homologous end-joining (NHEJ) pathway of
double-strand break (DSB) repair often requires DNA
synthesis to fill the gaps generated upon alignment
of the broken ends, a complex task performed in hu-
man cells by two specialized DNA polymerases, Pol
and Pol. It is now well established that Pol is the
one adapted to repair DSBs with non-complementary
ends, the most challenging scenario, although the
structural basis and physiological implications of
this adaptation are not fully understood. Here, we
demonstrate that two human Pol point mutations,
G174S and R175H, previously identified in two dif-
ferent tumor samples and affecting two adjacent
residues, limit the efficiency of accurate NHEJ by
Pol in vitro and in vivo. Moreover, we show that this
limitation is the consequence of a decreased tem-
plate dependency during NHEJ, which renders the
error-rate of the mutants higher due to the ability of
Pol to randomly incorporate nucleotides at DSBs.
These results highlight the relevance of the 8 kDa do-
main of Pol for accurate and efficient NHEJ, but also
its contribution to the error-prone behavior of Pol at
2-nt gaps. This work provides the first demonstration
that mutations affecting Pol identified in tumors can
alter the efficiency and fidelity of NHEJ.
INTRODUCTION
Double-strand breaks (DSBs) are one of the major threats
to cell viability as they can directly lead to cell death if un-
repaired (1). Eukaryotes are endowed with at least two ma-
jor pathways devoted to DSB repair, homologous recom-
bination (HR) and non-homologous end joining (NHEJ)
(2), although recently, the existence of an additional mech-
anism for DSB repair, termed microhomology-mediated
end joining (MMEJ) or alternative NHEJ (a-NHEJ), has
become more evident (3,4). Among these three pathways,
NHEJ is characterized by operating by directly rejoining
the broken ends requiring little or no microhomology and
limited resection (5). These characteristics render NHEJ
operative throughout the cell cycle (2), and arguably the
major pathway for DSB repair in mammalian cells. How-
ever, this mechanism of action also implies significant error-
proneness; in fact, NHEJ is frequently associated with short
deletions (5). Interestingly, the ends of a DSB are usually
imperfect for re-connection and their alignment can result
in mismatches and gaps that impede direct ligation. For
this reason, NHEJ generally requires processing prior to
ligation, which may involve DNA polymerases to fill the
gaps generated after alignment of the ends (5). NHEJ is ar-
guably the most demanding scenario for DNA synthesis, re-
quiring DNA polymerases to tolerate primer/template dis-
continuities, mismatches and even damaged bases, which
are frequently associated with DSBs (6). Accordingly, con-
ventional DNA polymerases are mostly inactive during
NHEJ and only highly specialized polymerases can synthe-
size DNA using these complex substrates.
DNA polymerases from the X family (PolXs) are small
monomeric enzymes specialized in filling small DNA gaps
either during NHEJ or base excision repair (BER) (7).
PolXs structural organization comprises a catalytic core
that consists of a polymerase domain and of an 8 kDa do-
main. The 8 kDa domain is essential to PolX adaptation to
filling small DNA gaps as it interacts specifically with the
downstream strand of the gap through one or more helix–
hairpin–helix motifs (HhH), and also through a positively
charged pocket that binds the 5′-phosphate (5′P) group of
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the downstream strand (7). In addition to the catalytic core,
PolXs specialized in NHEJ harbor an additional domain
termed BRCT (BRCA1 C-Terminal) that is strictly required
for the interaction with NHEJ core factors such as the
Ku70/80 heterodimer and the XRCC4/ligase IV complex
(8–12). Four PolXs have been identified in mammalian cells:
Pol, which is adapted to BER; Pol and Pol, which are
specialized in NHEJ; and TdT, which is adapted to gen-
erate diversity during V(D)J recombination. Interestingly,
although TdT activity was traditionally considered to be
strictly template-independent, recent studies demonstrate
that, similarly to Pol, TdT can bridge broken DNA ends
and incorporate template-directed nucleotides in this con-
text (13,14).
PolXs are highly conserved through evolution and analy-
sis of single PolXs orthologs suggest that NHEJ is arguably
their most ancestral role. Pol4, the only PolX found in both
budding and fission yeast, is a relevant example having been
shown to be specialized in NHEJ (15,16), and even to im-
pact chromosomal translocations in budding yeast (17). In
spite of the clear link between PolXs and NHEJ, the fact
that higher eukaryotes harbor two DNA polymerases spe-
cialized in NHEJ, Pol and Pol, suggested functional re-
dundancy. Nevertheless, multiple studies addressed this by
demonstrating that Pol and Pol are specialized in re-
pairing DSBs with ends of different complementarity, thus
having non-overlapping roles (10,18). Pol is specialized in
the repair of partially complementary broken ends and it
is uniquely accurate if the gaps to be filled have two tem-
plate nucleotides (nt). Pol accuracy in this context is re-
markable because other PolXs, such as Pol, can be par-
ticularly error-prone if the primer and downstream strands
of a gap are distant, as in the case of 2-nt gaps (18–22),
due to their inherent need to simultaneously interact with
both 3′ and 5′ends of the gap. Pol overcomes this problem
by scrunching the template DNA to stabilize the template
base that follows the first to be copied in an extrahelical
position (23). On the other hand, Pol is mainly special-
ized in the repair of DSBs with non-complementary ends,
an extremely complicated task given that the primer termi-
nus to be extended and the template DNA are not paired
in this context. Different studies have identified some struc-
tural features that enable Pol to synthesize DNA in such
a complicated scenario, and among them, Pol loop1 mo-
tif stands out. Loop1, also conserved and first defined in
TdT (24), is strictly required by Pol to operate at non-
complementary ends (10,20). In spite of the lack of direct
structural information for Pol loop 1, it was proposed to
act as a connector, bridging the unpaired primer-terminus
and 3′-protruding template portion of non-complementary
ends (10,20). Recent work supports that hypothesis, show-
ing for the first time a crystal structure in which TdT Loop
1 contributes to align and connect the two DNA ends of
a DSB (14). Pol ability to catalyze DNA synthesis using
non-complementary broken ends implies higher promiscu-
ity; in fact, Pol can also catalyse template-independent
synthesis, again strictly requiring loop 1 for this task (20).
Furthermore, analyses of sugar selectivity at the active site
of Pol also demonstrates a low discrimination (25,26), a
relevant feature for Pol-mediated NHEJ in vitro (27), and
paralleled by other PolXs such as TdT and Pol4 (28–30), re-
cently shown to be relevant for damage tolerance in the case
of the latter (31).
Although previous studies have clearly supported Pol
specialization in the NHEJ of non-complementary DSBs
and identified some of the structural elements of Pol re-
quired for this complex task, there are still some aspects of
this adaptation that remain unknown. Analyses of Pol and
Pol tumor variants helped to identify residues relevant for
their activity and even suggested that these mutations could
contribute to tumorigenesis as they led to increased muta-
genesis and genomic instability (32–35). In clear contrast,
whether tumor mutations of Pol could alter the proper-
ties of this enzyme has never been reported, and similarly
to the Pol and Pol analyses, this could be relevant not
only to evaluate the potential contribution of Pol to tu-
morigeneis but also to identify key structural elements re-
quired for NHEJ by Pol. Herein, we report the charac-
terization of two tumor-associated variants of Pol, G174S
and R175H, affecting two conserved adjacent residues lo-
cated in the 8 kDa domain. One of these adjacent residues,
Arg175, is known to directly bind the 5′P group of the down-
stream strand of the gap and accordingly, it was shown to be
relevant for Pol-mediated NHEJ (11). Conversely, the role
of the other residue, Gly174, remains unknown. Herein, we
demonstrate that the tumor mutations G174S and R175H
hinder the efficiency of Pol-mediated NHEJ both in vitro
and in vivo. Remarkably, the mutations specifically hamper
the incorporation of template-directed nucleotides but not
the insertion of untemplated and incorrect nucleotides at
DSBs, thus increasing the error rate of Pol during NHEJ.
Taken together our data highlight the relevance of the 8
kDa domain and more specifically of the Gly174 and Arg175
residues for efficient and accurate synthesis during NHEJ in
vitro and in vivo.
MATERIALS AND METHODS
DNA and proteins
Human wild-type Pol and the G174S and R175H mu-
tants were purified as previously described (36). The G174S
and R175H mutants were devised by site-directed mu-
tagenesis on the over-expressing construct pRSET-hPol
(37), using the QuickChange Site-Directed Mutagenesis Kit
(Stratagene) and the following synthetic oligonucleotides as
primers: G174S-forward (5′-GAAGGCAGTGAGAGCC
GCCTCCTCACC-3′) and G174S-reverse (5′-GGTGAG
GAGGCGGCTCTCACTGCCTTC-3′) in the case of the
G174S mutant; R175H-forward (5′-GGCAGTGAGGGC
CACCTCCTCACCTTC-3′) and R175H-reverse (5′-GAA
GGTGAGGAGGTGGCCCTCACTGCC-3′) in the case
of the R175H mutant. DNA oligonucleotides for site-
directed mutagenesis were purchased from Sigma-Aldrich.
Synthetic DNA oligonucleotides used for DNA polymer-
ization assays were purchased from Isogen and purified by 8
M urea–20% polyacrylamide (w/v) gel electrophoresis. Syn-
thetic oligonucleotides used as primers were radiolabeled
using [ -32P]ATP (3000 Ci/ mmol) (Perkin-Elmer) and T4
polynucleotide kinase (New England Biolabs) for 45 min at
37◦C. Hybridizations were performed in 1× hybridization
buffer (50 mM Tris–HCl pH 7.5, 0.3 M NaCl) for 10 min
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at 80◦C. Unlabeled ultrapure dNTPs were supplied by GE
Healthcare.
DNA polymerization assays
For 1 nt gap-filling assays, a 5′[32P]-labeled 15-mer DNA
primer (5′- GATCACAGTGAGTAC-3′) was hybridized
to a 28-mer template (5′-AGAAGTGTATCTCGTACTCA
CTGTGATC-3′) and to a 12-mer downstream oligonu-
cleotide harboring a 5′P (5′P-AGATACACTTCT-3′) to
generate a dsDNA molecule with a 1 nt gap. DNA (2.5
nM) was incubated with purified Pol (25 nM) and the in-
dicated amounts of dGTP for 30 min at 30◦C. The reac-
tion mixture (20 l) contained 2.5 mM MgCl2 and 1X re-
action buffer (50 mM Tris-HCl/ pH 7.5, 1 mM DTT, 4%
glycerol and 0.1 mg/ml BSA). After incubation, reactions
were stopped by addition of loading buffer (95% (v/v) for-
mamide, 10 mM EDTA, 0.1% (w/v) xylene cyanol and 0.1%
(w/v) Bromophenol Blue), and primer extension was an-
alyzed by 8 M urea–20% polyacrylamide (w/v) gel elec-
trophoresis. After electrophoresis, extended products were
detected using a BAS-1500 phosphorimager (Fujifilm) and
band intensities were determined by densitometry. For 2
nt gap-filling assays, a 5′[32P]-labeled 15-mer DNA primer
(5′-TCTGTGCAGGTTCTT-3′) was hybridized to a 32-
mer template (5′-TGAAGTCCCTCTCGACGAAGAAC
CTGCACAGA-3′) and to a 15-mer downstream oligonu-
cleotide harboring a 5′P (5′P-TCGAGAGGGACTTCA-3′)
to generate a 2 nt-gapped dsDNA. Reactions were per-
formed as described above for the 1-nt gap-filling exper-
iments but using the indicated concentrations of either
dCTP or dGTP. After 30 min of incubation at 30◦C, primer
extension was analysed as described previously.
To test the ability of Pol to perform NHEJ of compat-
ible ends in vitro, a 5′[32P]-labeled 13-mer DNA (5′-CCC
TCCCTCCCGT-3′) was hybridized to an 11-mer oligonu-
cleotide (5′-GGGAGGGAGGG-3′) to generate a labeled
dsDNA primer molecule with a 3′-protruding end. Addi-
tionally, a 15-mer oligonucleotide (5′-GCACTCACGTC
CCCA-3′) was hybridized to a 13-mer oligonucleotide har-
boring a 5′P (5′P-GGGACGTGAGTGC-3′) to generate an
unlabeled dsDNA molecule with a 3′-protruding end that
will be recognised mainly a as a template by Pol due to
the presence of a 5′P group flanking the protrusion. Re-
actions were performed by incubating the labeled DNA (7
nM) with the unlabeled DNA (18 nM), in the presence of
200 nM of purified Pol. The reaction mixture (20 l) also
contained 2.5 mM of MgCl2, 1× reaction buffer and the
indicated amounts of dGTP. After 30 min of incubation
at 30◦C, primer extension was analysed as described pre-
viously.
To assess the effect of the mutations on the NHEJ of
non-compatible ends in vitro, a 5′[32P]-labeled 12-mer DNA
primer (5′-CCCTCCCTCCCN-3′, where N = dA or dC)
was hybridized to the 11-mer oligonucleotide (5′-GGG
AGGGAGGG-3′), to generate a labeled dsDNA primer
with a 3′-protrusion of 1 nt. A 14-mer oligonucleotide (5′-
GCACTCACGTCCCN-3′, where N = dA or dC) was hy-
bridized to the 13-mer oligonucleotide harboring a 5′P
(5′P-GGGACGTGAGTGC-3′) to generate an unlabeled
dsDNA template molecule with a 3′-protrusion of 1 nt,
which was used in the assays only when indicated. Reac-
tions were performed as described above for NHEJ of com-
patible ends, using the indicated amounts of dGTP to test
the efficiency of template directed insertions, the indicated
amounts of dATP to test the efficiency of misinsertions, or
5 M of each individual dNTP to test the overall fidelity
of the NHEJ reaction. After incubation for 30 min at 30◦C,
primer extension was analysed as described previously.
Terminal transferase activity of Pol was assayed by in-
cubating 5 nM of a 5′[32P]-labeled 21-mer polydT with 600
nM of purified Pol and 100 M of each individual dNTP.
The reaction mixture (20 l) also contained 1 mM of MnCl2
and 1× reaction buffer. After 30 min of incubation at 37◦C,
reactions were stopped with loading buffer as described pre-
viously. Primer extension was also analysed as described
above.
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays were performed using
a 5′[ 32-P] labeled 13-mer oligonucleotide (5′-CCCTCCC
TCCCGT-3′) hybridized to a 11-mer oligonucleotide har-
boring a 5′P group (5′P- GGGAGGGAGGG-3′). Purified
Pol (either 200, 400 or 600 nM) was incubated with 14 nM
of the labeled DNA and 1× reaction buffer in a final volume
of 10 l. After 10 min of incubation at 30◦C samples were
mixed with 3 l of 30% glycerol and subsequently resolved
by native 4% polyacrylamide (w/v) gel electrophoresis. Af-
ter electrophoresis the gels were dried and the labeled DNA
was detected by either autoradiography or using a BAS-
1500 Phosphorimager (Fujifilm). Quantification of the re-
tarded enzyme:DNA complex was performed by ImageJ
quant software, and Kd values were determined using spe-
cific binding non-linear regression in Prism 6.0 (Graphpahd
Software).
Primary sequence alignments and 3D protein structure visu-
alization assays
Multiple alignments of aminoacid sequences were per-
formed using the MULTALIN server (38) (http://multalin.
toulouse.inra.fr/multalin/). 3D structural images were cre-
ated with the PyMol Molecular Graphics System (Version
1.2r2, Schrödinger), using the following PDB IDs: 4LZD
for human apoenzyme Pol, 4M04 for human Pol ternary
pre-catalytic complex, 4M0A for human Pol post-catalytic
complex (39), 1BPY for human Pol complexed with a
gapped DNA and ddCTP (40), 1XSN for Pol in complex
with a 1 nt-gapped DNA and ddTTP (41), 5D46 murine
TdT post-catalytic complex with a DSB with partially com-
plementary ends and 5D4B for murine TdT post-catalytic
complex with a DSB with native non-complementary ends
(14).
Extrachromosomal NHEJ repair assay
The cell lines used for the extrachromosomal repair assays
were prepared and maintained as described previously (18).
Substrates were assembled by ligation of ∼15 bp double-
stranded DNA caps (Table S1) containing the desired over-
hang sequence to a 280 bp core fragment digested with Bsai-
HF (NEB) at a ratio of 3:1 (cap:core). Substrates were then
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purified using a Qiaquick PCR purification kit (Qiagen),
and resolved on a native acrylamide gel to ensure substrates
preparations were free of unappended core and excess cap.
The extrachromosomal repair assays were carried out as
previously described (18). Briefly, electroporations were per-
formed using the NEON transfection system (Invitrogen)
with 20 ng of substrate, 600 ng pMAX-GFP carrier plas-
mid, and 2 × 105 cells using a 1350 V, 30 ms pulse in a 10
l chamber. Following transfection, cells were incubated in
antibiotic-free media for 1 h at 37◦C. Cellular DNA was
then harvested using a QiAamp DNA mini kit (Qiagen).
Each electroporation was repeated three times on different
days. Transfection experiments with protein complementa-
tion were carried out as described above with the addition
of purified protein (10 or 100 ng) to the substrate transfec-
tion solution immediately before electroporation.
Repair junctions were amplified using Cy5-labeled PCR
primers and characterized by restriction enzyme digests.
The restriction enzymes used for each substrate were as
follows: SalI for the +G junctions of the C3′ substrate,
Hpy166III for the +X junctions of the C3′ substrate, AfeI
for the +C junctions of the GCG3′ substrate, MluI for the
+C products of the GACG3′ substrate, or AatII for the +TC
products of the GACG3′ substrate. Digestion products were
resolved on a 5% non-denaturing polyacrylamide gel, visu-
alized using a Typhoon Imager (GE Healthcare), and quan-
tified using ImageJ software.
RESULTS
Structural analysis and evolutionary conservation of Pol
Gly174 and Arg175
Previous studies compiled in the COSMIC database (http:
//cancer.sanger.ac.uk/cosmic) (42), have identified two hu-
man Pol point mutations, G174S and R175H, described
in skin and ovary carcinomas, respectively (43,44). These
tumor mutations affect two adjacent residues, Gly174 and
Arg175, located within the 8 kDa and in close proximity to
the template/downstream base pair forming the 5′ side limit
of a DNA gap (Figure 1A). Gly174 is positioned near the
template base that is paired to 5′ end-terminal base of the
downstream strand flanking the gap (Figure 1A). Interest-
ingly, Pol and Pol harbor a histidine (His34) or a trypto-
phan (Trp274) respectively at that position (Figure 1B and
C), that can perform stacking interactions with the tem-
plate base ring moiety and that are highly evolutionary con-
served in Pol and Pol from vertebrates (Supplementary
Figure S1A and B). Conversely, the small size of Gly174 min-
imizes interaction with the DNA, which could suggest a
minimal interference with sporadic distortions of the tem-
plate molecule. As previously reported, Arg175 directly in-
teracts with the 5′P group of the downstream strand when
Pol is bound to a DNA gap (Figure 1A; first reported for
murine Pol (45)). Analysis of Pol structure suggests that
Arg175 may be the most relevant ligand of the 5′P group
compared to the other ligand, His208. Accordingly, muta-
tion of Arg175 to alanine pronouncedly diminishes Pol ac-
tivity during NHEJ (11). The recently solved structures of
the catalytic cycle of a gap filling reaction by human Pol
show that Arg175 is mobile when Pol is not bound to the
DNA and consequently its side chain is not visible in this
context (Figure 1D, left panel); however, interaction with
the 5′P of a DNA strand stabilizes its conformation (Fig-
ure 1D, right panel), supporting a relevant role for Arg175
in DNA binding.
Primary sequence alignment of Pol orthologs shows
that both Gly174 and Arg175 are highly conserved in verte-
brates (Figure 1C), supporting their functional relevance.
A more exhaustive alignment showed that Arg175 is more
strictly conserved than Gly174, that can be changed to other
residues such as cysteine, valine and alanine, in a few Pol
orthologs (Supplementary Figure S2), and possibly, muta-
tion of Gly174 to serine in Pol (as in the tumor variant
G174S) could have functional implications, as serine is a
small but polar residue. The R175H mutation might also
affect the optimal function of Pol given that histidine in-
teraction with a 5′P could be expected to be weaker than
that of arginine, given that at a physiological pH, histidines
are generally not positively charged, unlike arginines. The
possible relevance of Pol Arg175 is also supported by its
invariance in Pol (Arg273) and by the presence of a conser-
vative substitution in Pol (Lys33) (Supplementary Figure
S1A and B) the two other human PolXs that strongly bind
the 5′P of the downstream DNA strand flanking a gap (46–
48). Interestingly, both Gly174 and Arg175 are not conserved
in human TdT, possibly suggesting that these residues and
this area of the 8 kDa domain are especially important for
template-dependent reactions. In fact, the important vari-
ability observed at these corresponding positions in TdT
among vertebrates also supports this idea (Supplementary
Figure S1C). Strikingly, a recent study demonstrated that
introducing an arginine in murine TdT (replacing Ser187),
enhanced TdT template-dependent activity (14).
The G174S and R175H mutations limit the efficiency of ac-
curate NHEJ by Pol both in vitro and in vivo
To determine the effect of the G174S and R175H muta-
tions on the activity of human Pol, we devised the mu-
tants by site-directed mutagenesis and purified the recom-
binant proteins. First, the ability of the mutants to fill a 1
nt-gap was tested by incubating the purified proteins with
a 5′-labeled dsDNA containing a 1 nt-gap flanked by a 5′P
(Figure 2A, see scheme), a group known to stimulate the
activity of Pol in vitro. The R175H mutation did not al-
ter the efficiency of primer extension by Pol during gap-
filling of a 1 nt-gap compared to its wild-type counterpart
(Figure 2A), in clear contrast to what was described for
the R175A mutation, which was partially defective in the
filling of 1 nt-gaps (11). It should be noted that we could
not detect extension of more than ∼50% of the primer
molecules, probably due to imperfect hybridization of the
DNA molecules. Regardless, this experiment suggests that,
although Arg175 is necessary for optimal gap-filling activ-
ity, a histidine can replace this residue for this task. Con-
versely, the G174S mutation reduced primer extension by
Pol during gap-filling, but very mildly (∼1.5-fold) (Fig-
ure 2A), suggesting that Gly174 is also not strictly required
for this reaction. Next, after demonstrating that the tumor
variants are active proteins and proficient in gap-filling in
vitro, we sought to test the possible effect of these mutations
on NHEJ, the major role of Pol in vivo. For this, we used
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Figure 1. Structure and conservation of human Pol Gly174 and Arg175. (A) Structure of the ternary pre-catalytic gap-filling complex of human Pol (PDB
ID: 4M04) showing Gly174 and Arg175 structure and localization. (B) Structural comparison of human Pol, human Pol and human Pol (PDB IDs:
4M04, 1BPY and 1XSN respectively). (C) Primary sequence alignments of the human PolX members and of the indicated vertebrate Pol orthologs. (D)
Arg175 in Pol apoenzyme (PDB ID: 4LZD), and in the ternary pre-catalytic gap-filling complex of Pol (PDB ID: 4M04).
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Figure 2. The effect of the G174S and R175H mutations on the efficiency of accurate NHEJ. (A) Analysis of the activity of either wild-type Pol or the
G174S and R175H mutants on a 1nt gapped DNA. Data represented are means of at least 3 independent experiments, and the error bars correspond to
the SD. (B) Kinetic analysis of the effect of the mutations on the efficiency of accurate NHEJ of complementary ends in vitro. Data are represented as in
(A) and correspond to at least 3 independent experiments. (C) In vitro kinetic analysis of the efficiency of accurate NHEJ of non-complementary ends by
Pol and the G174S and R175H tumor variants in vitro. Data are represented as in (A) and correspond to at least three independent experiments. (D)
Schematic representation of the extrachromosomal NHEJ cellular system. DNA substrates mimicking different types of DSBs and purified Pol were
electroporated into MEFs deficient for Pol (Pol−/−) and Pol (Polm−/−). Accurate NHEJ could be monitored by reconstitution of a restriction site in
the DNA substrates. (E) Study of the effect of the G174S and the R175H mutation on accurate NHEJ in the extrachromosomal cellular system using
DNA substrate mimicking a DSB with complementary ends. Protein complementation was carried out using 10 ng of the purified proteins and accurate
NHEJ of the substrates was analysed by measurement the generation of the +C junction repair product, in which the restriction site of the AfeI enzyme
was reconstituted by Pol activity (n = 3, error bars indicate SD, ****P < 0.0001, one-way ANOVA with P values adjusted by the Bonferroni method).
(F) Effect of the mutations on the NHEJ of non-complementary ends in the cellular system. Protein complementation was carried out using 10 ng of the
purified proteins and accurate NHEJ by Pol generated the +G junction productions that were detected by digestion of the recovered DNA with the Sal
I restriction enzyme (n = 3, Error bars indicate SD, ***P < 0.001, **** P < 0.0001, one-way ANOVA with P values adjusted by the Bonferroni method).
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two dsDNA molecules, one labeled (Figure 2B, depicted in
light grey) and the other unlabeled (Figure 2B, depicted in
dark grey), and that are endowed with 3′-protruding ends
that have a complementarity of 1 nt. After annealing of the
complementary ends, which is induced by the polymerase,
two 1 nt-gaps are formed, having either dC or dG as tem-
plate. Importantly, the presence of a gap-flanking 5′P only
in the unlabeled molecule, stimulates Pol to preferably use
this molecule as template (dC) and the 3′-protruding end
of the labeled molecule as a primer to be extended with
dGTP. In this NHEJ-related polymerase assay, that is per-
formed in the absence of other NHEJ factors, both the
R175H and G174S mutations decreased Pol efficiency of
incorporation of dGTP, the template directed nucleotide
(Figure 2B), approximately 2.5-fold and 5-fold respectively,
suggesting that Arg175 and Gly174 are required for optimal
NHEJ of complementary ends in vitro. Next, we evaluated
the effect of the tumor mutations G174S and R175H on
the NHEJ of non-complementary ends, the most specific
role of Pol in vivo (18). We performed a similar NHEJ in
vitro assay but using dsDNA molecules with 3′-protruding
non-complementary ends (Figure 2C, see scheme). The ex-
periment showed that both R175H and G174S mutations
markedly decreased Pol NHEJ efficiency when using non-
complementary ends in vitro (Figure 2C), (approximately 7-
and 15-fold respectively), more pronouncedly than during
the NHEJ of compatible ends (Figure 2B). Hence, these re-
sults demonstrate that the G174S and R175H tumor vari-
ants are defective in NHEJ in vitro, more markedly when
the broken ends are non-complementary, the most specific
context of Pol action. These results also support a relevant
role for these two residues of human Pol in NHEJ, already
demonstrated for Arg175 (11), but completely unknown in
the case of Gly174.
The pronounced defect caused by these mutations on
NHEJ in vitro, prompted us to validate these conclusions
in a physiological context. For this purpose, we took ad-
vantage of a recently described NHEJ extrachromosomal
system that operates through the co-electroporation of pu-
rified polymerases and specific DNA substrates mimick-
ing DSBs into Pol- and Pol-deficient mouse embryonic
fibroblasts (MEFs) (Figure 2D; (18)). After electropora-
tion, these DNA substrates are repaired by NHEJ inside the
MEFs, as demonstrated by the residual activity detected in
a Ku70 deficient background (18), and the accuracy NHEJ-
mediated repair is monitored by restriction digestion of the
substrate recovered from the cells (Figure 2D). Addition-
ally, the fact that the recipient cells lack endogenous Pol
and Pol implies that this accurate repair, which is medi-
ated by gap-filling and does not require nuclease process-
ing of the ends, completely relies on the co-electroporated
purified DNA polymerases (18). First, we used a DNA
substrate mimicking a DSB with 3′-protruding ends with
2nt of complementarity (Figure 2E). Accurate repair of the
substrate generates a product, referred to as +C junctions,
that is monitored by AfeI restriction. When no protein
was co-electroporated with the DNA, +C junctions were
barely detectable and only accounted for ∼2% of the total
DNA junctions recovered (Figure 2E). Co-electroporation
of wild-type Pol clearly stimulated the level of detectable
+C junctions, indicating that accurate NHEJ is enhanced
by Pol-mediated gap-filling (Figure 2E). Conversely, co-
electroporation of either R175H or G174S mutants only
produced a slight increase in accurate NHEJ efficiency com-
pared to the non-co-electroporated protein condition, and
led to 5-fold lower percentage of +C junction recovery com-
pared to the wild-type protein (Figure 2E). According to
our in vitro data, we expected a less pronounced defect in
the case of the R175H mutant compared to the G174S mu-
tant; however, the decrease in efficiency caused by the muta-
tions in vivo is overall similar to that observed in vitro when
using a comparable substrate (Figure 2B), further confirm-
ing that these tumor variants are defective in NHEJ. Next,
we performed a similar experiment electroporating a DNA
molecule that mimicks a non-complementary DSB. Faith-
ful repair by NHEJ of the molecule could be monitored
by digestion of the recovered with SalI restriction enzyme
(Figure 2E). As previously described, these events of faith-
ful repair, that we named +G junctions, were completely
Pol-dependent, as they are undetectable when this poly-
merase was not electroporated (Figure 2F) (18). Interest-
ingly, when Pol wild-type was co-electroporated with the
DNA into the MEFs, +G junctions were detectable and
accounted for 30% of the total repair events (Figure 2F),
however electroporation of either R175H or G174S tumor
variants significantly reduced the percentage of +G junc-
tions (∼3-fold in both cases) (Figure 2F), again suggesting
that the mutations reduce the ability of Pol to perform
accurate NHEJ efficiently. As this experiment is compara-
ble to others previously performed (18) that completely re-
lied on Ku70, we favor that it constitutes a valid assess-
ment of bona-fide classical NHEJ in vivo, although we do
not formally demonstrate this. Interestingly, it is also wor-
thy to note that the defect caused by the mutations in the
cellular system was less pronounced in the case of sub-
strate with non-complementary ends compared to the DNA
with complementary ends (Figure 2E), in clear contrast to
our in vitro data. In fact, this defect on the NHEJ of non-
complementary ends was also less pronounced than that
detected in the in vitro experiment when using a compa-
rable substrate (Figure 2C), which could suggest that the
presence of other NHEJ factors could alleviate the defect
caused by the mutations specifically during NHEJ of non-
complementary ends, which is Pol’s most specific task in
vivo. In any case, overall, our data unambiguously indicate
that the R175H and G174S tumor variants fail to perform
accurate NHEJ efficiently in vivo.
The G174S and R175H mutations lead to decreased fidelity
during NHEJ
Once demonstrated that the G174S and R175H mutations
hamper the efficiency of accurate NHEJ, we wanted to
evaluate whether this phenotype could impact their over-
all fidelity. For this purpose, either the tumor variants
or the wild-type control were incubated with the dsDNA
molecules mimicking a DSB with non-complementary ends
and 5 M of each of the 4 dNTPs, which were added to the
mix independently. Wild-type Pol incorporated dGTP, the
template directed nucleotide, much more efficiently than in-
correct nucleotides (Figure 3A, right panel); as a control,
incorporation of dGTP required the presence of the unla-
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Figure 3. Decreased fidelity caused by the G174S and R175H mutations on NHEJ in vitro. (A) Purified Pol and the G174S and R175H mutants (200
nM) were incubated with 5 M of each individual dNTP and the two DNA molecules mimicking a DSB with non-complementary ends to test the fidelity
of these reactions (right panel). The effect of the 5′P group flanking the template base on the fidelity of NHEJ was evaluated by repeating the experiment in
the absence of the unlabeled 3′-protruding DNA molecule (left panel). The data represented in the graphs are of at least three independent experiments and
the error bars correspond to the SD. ****P < 0.0001, ns, not significant, two-way ANOVA with P values adjusted by the Bonferroni method. (B) Schematic
representation of Pol-mediated end-bridging of the DNA molecules used in (A) explaining template-dependent and template-independent incorporation
of nucleotides. (C) Kinetic analysis of template-independent nucleotide incorporation by Pol at DSBs with non-complementary ends, measured by dATP
insertion, by Pol and the G174S and R175H mutants. Data are the means of at least two independent experiments and the SD is represented in the error
bars. (D) Analysis of the terminal transferase activity of Pol and the G174S and R175H mutants on homopolymeric DNA. (E) Effect of the G174S and
R175H mutation on DNA binding monitored by EMSA. The graph represents means of at three different experiments using the indicated concentrations
of either Pol wild-type or the G174S and R175H mutants, and the error bars show the standard error of the mean (SEM). Kd values were determined
using specific binding non-linear regression in Prism 6.0 (Graphpahd Software).
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beled molecule with the 5′P to be efficient (Figure 3A; com-
pare dGTP incorporation in both left and right panels).
Importantly, when the molecule harboring the 5′P was not
present in the assay, dGTP incorporation, although much
less efficient, was still detectable; and it could be due to the
‘alignment’ of two labeled molecules to use of one of the
3′ protruding dC as a template (Figure 3B). Interestingly,
wild-type Pol could also catalyse the incorporation of the
3 incorrect nucleotides, and with comparable efficiency ir-
respectively of the presence of the molecule with the 5′P
group (Figure 3A). Furthermore, in the absence of the DNA
ends with the 5′P, incorrect nucleotides were incorporated
as efficiently as dGTP, suggesting that when the phosphate
group that flanks the template base is absent, the templat-
ing base dC cannot be ‘read’ correctly by Pol, probably
due to defective binding and/or orientation of the two DNA
ends (Figure 3B). In fact, we speculate that these insertion
events are completed by virtue of the terminal transferase
activity of Pol (20), known to be limited by the presence
of 5′P groups (49), and therefore, they may not necessar-
ily involve simultaneous binding of two DNA molecules. In
agreement with our previous results, the G174S and R175H
variants incorporated dGTP (the accurate insertion when
the dC protruding end had a neighbor 5′P) less efficiently
than wild-type Pol (Figure 3A, right panel). The G174S
variant incorporated dGTP very inefficiently, being unaf-
fected by the presence/absence of the 5′P, and comparably
to the insertion of incorrect nucleotides (Figure 3A, com-
pare left and right panels). Strikingly, wild-type, R175H
and G174S gave very similar values of misincorporated nu-
cleotides in these NHEJ assays. The fact that dGTP incor-
poration by the Pol variants was slightly (R175H) or not
(G174S) stimulated by presence of a 5′P group flanking the
template base suggests that they cannot correctly bind or
orientate the 3′protrusion to serve as a template (Figure 3B).
Furthermore, kinetic analyses of dATP incorporation
further confirmed that the G174S and R175H mutations
did not affect incorporation of non-templated nucleotides
during NHEJ of non-complementary ends. Again, dATP
incorporation was as in the wild-type, and took place simi-
larly either in the absence or presence of a 5′P flanking the
dC template base (Figure 3C), further confirming that this
reaction does not occur via bona-fide NHEJ. Interestingly,
and irrespective of the 5′P group, certain sequence contexts
have been shown to impact Pol activity during NHEJ; for
instance, some bases, such as A, are poor templates during
Pol-mediated NHEJ of non-complementary ends in vitro,
as they seem to limit the efficiency of template directed ad-
ditions, rendering them comparable to non-templated inser-
tions (27). The tumor variants showed a similar rate of in-
corporation of dNTPs compared to the wild-type Pol  in
this sequence context (template A) (Supplementary Figure
S3). This behavior is consistent with the variants’ defect in
template-directed synthesis in NHEJ in vitro. As mentioned
earlier, we speculate that the incorporation of template-
independent nucleotides during NHEJ is due to the termi-
nal transferase activity of Pol. Also in line with our previ-
ous results, the G174S and R175H mutations did not affect
the terminal transferase activity of Pol measured by incor-
poration of dNTPs on a homopolymeric ssDNA molecule
(Figure 3D).
Taken together, our results demonstrate that the G174S
and R175H mutations specifically decrease Pol ability
to incorporate template-directed nucleotides during NHEJ
of non-complementary ends. The mutations on the other
hand, do not impact whatsoever the incorporation of incor-
rect dNTPs at DSBs, which likely occurs through terminal
transferase-like reactions. Hence, these results indicate that
these tumor mutations could impact the fidelity of Pol-
mediated NHEJ via interfering with template-dependent
selection of nucleotides in vivo. Given that the residues
affected by the mutations localize in the 8 kDa domain,
which is involved in binding the template/downstream
junction at a gap, the low efficiency of bona-fide NHEJ
caused by the mutations could be consequence of defective
binding/orientation of the templating base, either directly
or indirectly caused by a defective 5′P recognition. Elec-
trophoretic mobility shift assays indicated that the R175H
variant, but not the G174S, bound defectively to a 3′-
protruding DNA substrate harboring a 5′P next to the pro-
trusion (Figure 3E). This suggests that defective NHEJ by
R175H is thus a consequence of impaired DNA binding in
agreement with the fact that Arg175 is the main ligand of
the 5′P group. However, this experiment could also indicate
that although R175H and the G174S variants lead to a sim-
ilar phenotype, they might affect NHEJ differently, as the
G174S mutation apparently does not impair binding of the
DNA. We speculate that this mutation might impair proper
orientation of the templating base that is likely facilitated
by the small and flexible Gly174 in vivo.
The G174S and R175H mutations differentially impact 2nt
gap-filling by Pol
The adaptation of the members of the PolX family to fill-
ing small DNA gaps -a common DNA transaction in both
BER and NHEJ- relies on their 8 kDa domain, which al-
lows these polymerases to interact not only with the 3′ end
of the primer, like a conventional polymerase, but also with
the 5′ end of the downstream strand of the gap. Conse-
quently, PolXs can be particularly ineffective if these two
flanks of the gap are too distant. In fact, a recent in vivo
study demonstrated that in mammalian NHEJ, PolX ac-
tivity is mainly restricted to the filling of 1nt and 2nt gaps
(18). However, 2nt gaps are already a challenging scenario
for NHEJ PolXs: whereas Pol can accurately fill 2nt gaps
due to its unique ability to scrunch the template (23), Pol
lacks this capacity and is consequently more error-prone in
this context (18–22). In fact, when dealing with 2nt gaps,
Pol was shown to preferably copy the template base closer
to 5′ end of the downstream strand, rather than the first
template base, a reaction termed skipping-ahead that po-
tentially leads to frameshift mutations (18–22). Due to the
specific role of the 8 kDa in interacting with the 5′ end of the
downstream DNA strand, this domain has already been an-
ticipated to possibly influence Pol’s error-proneness dur-
ing the filling of 2nt gaps (22). Moreover, it could also be
anticipated that the lack of stacking interactions with the
base pair flanking the gap, a stark difference between Pol
and Pol or Pol (Figure 1B), could also have an influ-
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ence on how differently these enzymes behave on 2nt gaps.
Hence, we decided to address the role of the Gly174 and
Arg175 residues on the filling of 2nt gaps by Pol by ana-
lyzing the effect of the G174S and R175H mutations. For
this, we used a 5′-labeled dsDNA molecule harboring a 2nt
gap in which incorporation opposite the second template
base (skipping ahead) and opposite the first template base
(regular primer extension) could be monitored by incorpo-
ration of dGTP and dCTP respectively (Figure 4A). As ex-
pected, under these conditions, Pol was clearly more ef-
ficient (roughly 7-fold) using the second template base to
direct nucleotide incorporation (dGTP in this case) rather
than the first, although it could use either of them for catal-
ysis (Figure 4B, note the different scale of nucleotide con-
centration). Strikingly, the R175H mutation pronouncedly
decreased the overall efficiency of Pol in both reactions, so
markedly that incorporation of the nucleotide complemen-
tary to the first template base (dCTP) was not detected in
the experiment (Figure 4B). Consequently, these data indi-
cate that Arg175 is indispensable for the filling of 2nt gaps by
Pol, and that a histidine cannot replace it for this task, sim-
ilarly to what was observed in the NHEJ experiments (Fig-
ure 2). Conversely, this result contrasts with that obtained
in a 1nt gap-filling assay (Figure 2A), where the R175H had
no detectable defect, suggesting that the 2nt gap is a more
challenging scenario, likely more dependent on an optimal
interaction with the 5′P of the downstream strand. On the
other hand, the G174S mutation led only to a moderate de-
crease in efficiency (∼1.5-fold) in the skipping-ahead reac-
tion compared to wild-type Pol, but an improved (∼2.5-
fold) conventional incorporation of the nucleotide com-
plementary to the first template base (Figure 4B). Hence,
although the G174S mutants still showed a clear prefer-
ence for the skipping-ahead reaction, it performed this re-
action only 2.5-fold more efficiently than the incorporation
of nucleotides opposite the first template base, in contrast
to wild-type Pol that skipped-ahead 7.1-fold higher effi-
ciency (Figure 4C). Overall, these data suggest that Gly174
and Arg175 have different impact on 2nt gap-filling by Pol;
while Arg175 is required for any reaction mediated by Pol
involving a 2nt gap, Gly174 limits nucleotide incorporation
opposite the first template base. Further analyses using
the cellular NHEJ system indicated that both G174S and
R175H mutants decreased similarly (2-fold) the ability of
Pol to perform skipping-ahead reactions on 2nt gaps dur-
ing NHEJ, consequent with their effect on these reactions
and their overall limitation during NHEJ (Supplementary
Figure S4). However, likewise wild-type Pol, the mutants
could not fill the 2nt gap by incorporating 2 nucleotides and
extending the primer normally, suggesting that, although
Gly174 limits normal primer extension at 2nt-gaps in vitro,
its mutation to serine may not be sufficient to perform ac-
curate 2nt gap-filling in vivo.
DISCUSSION
The genetic alterations leading to the transformation of a
normal cell into a cancer cell are commonly point muta-
tions (e.g. insertion, deletions, single base modifications),
and due to the role of DNA polymerases as DNA synthe-
sizers, alterations in the function and fidelity of these en-
zymes could contribute somehow to the accumulation of
these mutations, and in turn to the tumorigenesis process
(nicely reviewed in (50)). Several evidence argue in favor of
this idea as for instance Pol and Pol exonuclease-deficient
mice have shorter lifespans and highly increased frequency
of carcinogenesis (51–53), but in the case of most DNA
polymerases, whether they may contribute to tumorigen-
esis is not fully understood. Among the members of the
PolX family, Pol is the best studied in this context as some
tumor-associated point mutants of Pol were shown to in-
duce mutations (32,33), and their expression to cause cellu-
lar transformation (34). Pol could also impact tumorigene-
sis, given that a single point mutation associated to colorec-
tal cancer was shown to decrease Pol fidelity and to lead to
increased genomic instability (35), a common characteristic
of cancer cells. Remarkably, these studies are relevant not
only because they shed light on whether the altered function
of these polymerases could contribute to tumorigenesis but,
from a structural and functional standpoint, because they
identified critical residues for function of these polymerases.
In this work, we have characterized two tumor-associated
Pol point mutantions, G174S and R175H, previously
identified in two different tumor samples (43,44). We have
demonstrated that these mutations impact similarly the ac-
tivity of Pol during NHEJ decreasing both its efficiency
and fidelity, due to the fact that they lead to impaired in-
corporation of template-directed nucleotides (Figure 2). As
shown, bona-fide NHEJ reactions by Pol require the pres-
ence of a 5′P group flanking the template base, which en-
hances both the fidelity and efficiency of these reactions
(Figure 3). In fact, the absence of this group leads to the
random incorporation of nucleotides at DSBs by Pol, a
natural consequence of its inherent terminal transferase ac-
tivity (Figure 3). Remarkably, the G174S and R175H mu-
tants were as proficient as wild-type Pol in these terminal-
transferase events, but in contrast to their wild-type coun-
terpart, their activity did not respond to the presence of
the 5′P flanking the template base (Figure 3A), suggesting
that their defective activity is somehow related to an im-
paired recognition of the 5′P during NHEJ. Arg175 is a lig-
and of the 5′P group itself, hence the effect of the R175H
mutation is not surprising, especially taking into account
the previously reported effect of Arg175 mutation to alanine,
shown to hamper binding to the DNA, bridging of broken
ends, and overall, the activity of Pol on any DNA sub-
strate harboring that group (11). Arg175 mutation to histi-
dine, although detrimental, was not as dramatic as mutation
to alanine since the R175H mutant retained normal activ-
ity 1n-gapped substrates (Figure 2A). Interaction with 5′P
group has already been reported to be essential for the ac-
tivity of most of the studied template-directed polymerases
from the X-family (e.g., (14,30,46–48)) and the study of
R175H further supports the idea. In line with this, it is in-
teresting to note that other template-directed PolXs, such
as Pol and Pol, harbor similar or equivalent residues at
the corresponding position of Arg175, and also that this
residue is not conserved in TdT, a polymerase with strong
template-independent activity that displays no positively
charged residues interacting with the 5′P within the 8 kDa
domain. Moreover, this 5′P biding pocket at the 8 kDa do-
main, absent in TdT and that includes Arg175 in Pol, is less
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Figure 4. Analysis of the effect of the G174S and R175H mutations on 2nt gap-filling by Pol in vitro. (A) Schematic representation of two alternatives
for 2nt gap filling by Pol: copying the second template base (skipping-ahead) or copying the first template base (regular primer extension). (B) Effect of
the G174S and R175H mutations on the efficiency of both reactions measured by dGTP and dCTP incorporation, respectively. Data represent means of
triplicate experiments and the error bars the SD. (C) Relative incorporation of 25 nM dGTP and 25 nM dCTP (taken from B) by wild-type or mutant Pol.
Bars correspond to the superimposition of the percentage of primer extension with dGTP (black) and dCTP (gray). The number above the Pol wild-type
and the G174S bar was calculated by dividing primer extension with dGTP by primer extension with dCTP.
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Figure 5. Modeling of human Pol in a NHEJ reaction. The human Pol polypeptide (in green) and the incoming nucleotide (dUTP; in yellow) were
taken from PDB ID: 4M04, and modeled with a DSB with 2 bp-complementary ends (coral and blue) and Loop1 (magenta) derived from a co-crystal of
mouse TdT (PDB ID: 5D46). The neighbor residues Gly174 and Arg175, studied in this paper, are indicated.
positively charged in Pol than in Pol and Pol, the latter
two lacking template-independent activity. This could sug-
gest that interaction with the 5′P limits terminal transferase
activity, as was previously shown for Pol (49). Moreover,
this could also suggest that mutation of the interactors of
the 5′P in Pol, as in the case of the R175H mutant, can
limit template-directed nucleotide insertions at DSBs.
However, it has been recently demonstrated that TdT can
perform template-directed nucleotide insertions at DSBs,
and suggested that these reactions may occur only after ad-
dition of non-templated nucleotides (14). Interestingly, in-
troduction of an arginine in mouse TdT enhanced the in-
corporation of template-directed nucleotides (14), in full
accordance with the role of this residue as a DNA ligand
for NHEJ in Pol. Interestingly, the overimposition of the
structure of human Pol:DNA-gap post-catalytic complex
to the structures of mouse TdT-DSB post-catalytic com-
plexes with a DSB with partially complementary or non-
complementary ends (14; the first of this kind in the case
of PolX members), provides an excellent fit at the area of
Arg175 and Gly174 (Supplementary Figure S6). This allowed
us to make a structural extrapolation of Pol in a NHEJ
context (Figure 5), which emphasizes the direct role of Loop
1 in connecting the two ends in both TdT and Pol, and fur-
ther supports that Arg175 in particular plays a direct role as
DNA ligand during NHEJ, as shown in this paper. How-
ever, additional studies aimed to determining the structure
of Pol in complex with a DSB would be needed to further
validate these conclusions.
Analysis of the R175H mutant also lead to another rel-
evant conclusion: interaction with the 5′P flanking the gap
is essential for the efficiency of Pol on 2nt gaps. Several
studies have demonstrated that when Pol faces a 2 nt gap
it preferably copies the second template base, which is the
one closer to the 5′ end of the downstream DNA, at the
cost of skipping the first available template base (18–22).
This error-prone behavior is a stark difference between Pol
and Pol, since the latter was shown to correctly fill 2nt
gaps in vivo (18), thanks to its unique template scrunch-
ing ability (23). Interestingly, our work also indicates that,
although the G174S and R175H mutations caused a simi-
lar defect in NHEJ, this was not the case in 2nt gap-filling
reactions, indicating that they are defective NHEJ for dif-
ferent reasons. In fact, the G174S mutation was not dele-
terious for 2nt gap-filling, as it stimulated nucleotide incor-
poration opposite the first template base, decreasing –but
not reverting- the preference of Pol for the skipping ahead
reaction. As mentioned earlier, Pol harbors at the corre-
sponding position of Gly174 a tryptophan (Trp274), a bulky
residue that performs stacking interaction with the template
base paired to the 5′P-containing nucleotide that limits the
gap. This stark difference was noticed when the structure
of Pol was first solved (45), although this has never been
understood. Given the stimulating effect of Gly174 on skip-
ping ahead during 2nt gap-filling by Pol, it is temping to
speculate that stacking interactions with the template DNA
proximal to the gap may limit skipping ahead at 2nt gaps
in the case of Pol. Comparison of the structures of Pol
bound to a 1nt gap and to a 2nt gap reveals that Trp274 is
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placed in close proximity to where the DNA is scrunched
by Pol in a 2nt gap (Supplementary Figure S5), and that
in fact, it moves accordingly to the template DNA when it
is scrunched (Supplementary Figure S5), suggesting that it
may contribute to this process. In any case, the dramatic ef-
fect that the G174S mutation had on NHEJ by Pol, both
in vivo and in vitro, suggests that, in contrast to Pol, Pol
requires a small, flexible and non-polar residue at that po-
sition to perform NHEJ efficiently, although at the cost of
enhanced error-proneness at 2nt gaps. The fact that R175H
and G174S showed similar defectiveness during NHEJ, but
that only the latter was more effective in 2nt gaps indicates
that the defect caused by the G174S mutation in NHEJ pro-
ceeds via inappropriate orientation of the DNA, but not by
defective DNA binding. Different positioning of the DNA
by the G174S mutant could explain why it incorporates nu-
cleotides opposite the first template base of a DNA 2nt-gap
more efficiently than wild-type Pol. Moreover, unaffected
binding of this mutant is in agreement with the fact that
Gly174 is not a ligand of the 5′P group, unlike Arg175. Our
EMSA experiments support this idea, as only the R175H
mutant showed a DNA binding defect. Hence, we speculate
that Gly174, being such a small and flexible residue, could al-
low maximal movement of the templating base so that Pol
can correctly orientate it for catalysis. This could be partic-
ularly relevant for NHEJ, especially of non-complementary
ends where the primer and primer and template are not
physically connected.
Overall, our characterization of the G174S and R175H
mutants highlights the relevance of the characterization
of tumor-associated variants of DNA polymerases for
structure–function analyses and to anticipate to certain ex-
tent whether they could contribute to tumorigenesis. How-
ever, we must emphasize that our work does not establish a
direct link between Pol and the tumorigenesis process it-
self. Given that some consider that an early tumorigenesis
step may be the mutation of genes that modulate the fidelity
of DNA repair to increase the frequency of mutagenesis
(54), it is tempting to speculate that the G174S and R175H
could contribute to the process, due to their increased error-
proneness during NHEJ in vitro. Although we have no ex-
plicit measurement of their fidelity of synthesis in vivo, the
in vitro data suggests that they could lead to increased mu-
tagenesis in vivo in response to DSBs. Furthermore, even if
these mutants do not display increased error-proneness in
vivo, defective Pol activity in vivo could lead to remodel-
ing of the DNA ends, implying end resection and loss of
genetic information, so that they become compatible with
repair by Pol-mediated NHEJ. Regardless, further studies
are required to determine the real impact of the G174S and
R175H on tumor development, if any.
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Piris,M.A., Bernad,A. and Blanco,L. (2004) Overexpression of
human DNA polymerase mu (Pol mu) in a Burkitt’s lymphoma cell
line affects the somatic hypermutation rate. Nucleic Acids Res., 32,
5861–5873.
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